Cargando…
Genetic variants in the circadian rhythm pathway as indicators of prostate cancer progression
BACKGROUND: To determine the association between circadian pathway genetic variants and the risk of prostate cancer progression. METHODS: We systematically evaluated 79 germline variants in nine circadian pathway genes in a cohort of 458 patients with localized prostate cancer as the discovery phase...
Autores principales: | Yu, Chia-Cheng, Chen, Lih-Chyang, Chiou, Chih-Yung, Chang, Yu-Jia, Lin, Victor C., Huang, Chao-Yuan, Lin, I-Ling, Chang, Ta-Yuan, Lu, Te-Ling, Lee, Cheng-Hsueh, Huang, Shu-Pin, Bao, Bo-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451277/ https://www.ncbi.nlm.nih.gov/pubmed/30996687 http://dx.doi.org/10.1186/s12935-019-0811-4 |
Ejemplares similares
-
Effect of genetic variants in cell adhesion pathways on the biochemical recurrence in prostate cancer patients with radical prostatectomy
por: Yu, Chia‐Cheng, et al.
Publicado: (2019) -
Genetic association analysis identifies a role for ANO5 in prostate cancer progression
por: Yu, Chia‐Cheng, et al.
Publicado: (2020) -
Genetic variants of the autophagy pathway as prognostic indicators for prostate cancer
por: Huang, Chao-Yuan, et al.
Publicado: (2015) -
Prognostic Value of CD1B in Localised Prostate Cancer
por: Lee, Cheng-Hsueh, et al.
Publicado: (2019) -
NRG1 Genetic Variant Influences the Efficacy of Androgen-Deprivation Therapy in Men with Prostate Cancer
por: Huang, Shu-Pin, et al.
Publicado: (2021)